Employer Active
Job Alert
You will be updated with latest job alerts via emailJob Alert
You will be updated with latest job alerts via emailNot Disclosed
Salary Not Disclosed
1 Vacancy
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS (linaclotide) the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide a next-generation long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases including short bowel syndrome with intestinal failure as well as several earlier stage assets. Building upon our history of GI innovation we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Founded in 1998 Ironwood Pharmaceuticals is headquartered in Boston Massachusetts and has operations in Basel Switzerland.
Position Overview:The Head of Clinical Operations will lead and will be accountable for the global clinical operations team responsible for the Apraglutide development program and oversee activities for Ironwood portfolio assets. This role ensures the successful planning and execution of clinical trials within timelines quality standards and budget. Reporting to the Senior Vice President of Research and Development the Head of Clinical Operations will spearhead operational excellence and oversee adherence to regulatory requirements and company SOPs while managing both internal and external resources for clinical trial activities.
Key Responsibilities:
Qualifications:
Skills and Competencies:
Location:
#LI-Hybrid
Required Experience:
Director
Full Time